VenoStent: Funding, Investors & Team (Oct 2026)
VenoStent develops medical devices intended to enhance the quality and longevity of patients undergoing dialysis. The device of the company is made of a new class of shape-memory polymers used in coronary artery bypass surgery mainly as an external stent that requires no sutures, allowing physicians to reduce surgery time, risk of infection, and wound re-opening of patients with hemodialysis, while also reducing venous occlusion failure.
VenoStent has raised $2.3M across 1 funding round on record, the most recent a Seed of $2.3M announced in Feb 2021.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
VenoStent Company Profile and Key Stats
Latest funding round on record: Feb 2021.
VenoStent Funding Rounds
VenoStent Founders and Leadership Team
No contact details are on record for this team yet.
VenoStent Funding Compared to Other Health Care Startups
VenoStent's latest round of $2.3M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like VenoStent in Health Care and Nashville
Companies Similar to VenoStent
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
VenoStent Funding FAQs
What does VenoStent do?
VenoStent develops medical devices intended to enhance the quality and longevity of patients undergoing dialysis. The device of the company is made of a new class of shape-memory polymers used in coronary artery bypass surgery mainly as an external stent that requires no sutures, allowing physicians to reduce surgery time, risk of infection, and wound re-opening of patients with hemodialysis, while also reducing venous occlusion failure.
How much funding has VenoStent raised?
VenoStent has raised $2.3M across 1 round on record. The most recent is a Seed of $2.3M announced in Feb 2021.
When did VenoStent last raise funding?
VenoStent's most recent funding round on record is a Seed of $2.3M, announced in Feb 2021.
Who is the CEO of VenoStent?
Timothy Boire is listed as CEO at VenoStent.
Where is VenoStent headquartered?
VenoStent is based in Nashville, Tennessee, United States.
How many employees does VenoStent have?
VenoStent is in the 1-10 employee band.
How does VenoStent's funding compare to other Health Care startups?
VenoStent's latest round of $2.3M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's VenoStent Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for VenoStent is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.